Carcinogenic NMDA Contamination of Drugs for Heartburn, Hypertension and Diabetes
- PMID: 33942664
- PMCID: PMC8204592
- DOI: 10.1177/10732748211011954
Carcinogenic NMDA Contamination of Drugs for Heartburn, Hypertension and Diabetes
Keywords: NMDA; angiotensin receptor blockers; cancer; metformin; ranitidine.
References
-
- U.S. Food and Drug Administration. What to Know and Do About Possible Nitrosamines in Your Medication. Published 2020. Accessed April 14, 2021. https://www.fda.gov/consumers/consumer-updates/what-know-and-do-about-po...
-
- U.S. Food and Drug Administration. Control of Nitrosamine Impurities in Human Drugs Guidance for Industry. Published 2020. Accessed April 14, 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents...
-
- U.S. Food and Drug Administration. Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit. Published 2020. Accessed April 14, 2021. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/nost...
-
- McRorie JW., Jr Heartburn: lifestyle modifications and over-the-counter medications. Nutrition Today. 2018;53(1):18-25. doi:10.1097/NT.0000000000000244
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources